Literature DB >> 6347831

Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.

M Bernardi, F Trevisani, C Santini, R De Palma, G Gasbarrini.   

Abstract

Thirty-seven patients with liver cirrhosis (16 without ascites: group 1; 21 with untreated ascites at the first onset: group 2) were studied during controlled sodium intake (40 mmol/day). Renal plasma flow, glomerular filtration rate, urinary sodium excretion, plasma sodium and potassium, plasma renin activity, plasma aldosterone concentration, blood volume, and arterial pressure were evaluated. All the patients had normal renal perfusion, plasma sodium and potassium, and arterial pressure. Mean plasma renin activity and plasma aldosterone concentration were significantly depressed in group 1 (p less than 0.001, p less than 0.005 respectively) compared with 21 normal controls in identical experimental conditions. This was possibly a consequence of expanded blood volume (p less than 0.001 compared with controls) which was directly correlated with plasma aldosterone concentration (p less than 0.001). In group 2 plasma renin activity and plasma aldosterone concentration were normal in over 50% of cases. Blood volume was lower than in group 1 (p less than 0.002), but again related to plasma aldosterone concentration (p less than 0.01). In both groups plasma aldosterone concentration was hyperbolically and inversely correlated with urinary sodium excretion, but the two curves were progressively shifted to the left in respect to controls suggesting an enhanced renal tubular sensitivity to the hormone. The results suggest that aldosterone related renal sodium retention, with consequent blood volume expansion, occurs before ascites formation. The mineralocorticoid activity of aldosterone is amplified by an enhanced sensitivity of renal tubules which appears to increase as the disease progresses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347831      PMCID: PMC1420242          DOI: 10.1136/gut.24.8.761

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  AN EXTRA-ADRENAL FACTOR ESSENTIAL FOR CHRONIC RENAL SODIUM RETENTION IN PRESENCE OF INCREASED SODIUM-RETAINING HORMONE.

Authors:  J O DAVIS; J E HOLMAN; C C CARPENTER; J URQUHART; J T HIGGINS
Journal:  Circ Res       Date:  1964-01       Impact factor: 17.367

2.  Blood volume in patients with Laennec's cirrhosis of the liver as determined by radioactive chromium-tagged red cells.

Authors:  S EISENBERG
Journal:  Am J Med       Date:  1956-02       Impact factor: 4.965

3.  Characterization of the renin-aldosterone system in decompensated cirrhosis.

Authors:  M Epstein; R Levinson; J Sancho; E Haber; R Re
Journal:  Circ Res       Date:  1977-12       Impact factor: 17.367

4.  Plasma renin level in hepatic cirrhosis. Relaton to functional renal failure.

Authors:  E T Schroeder; R H Eich; H Smulyan; A B Gould; G J Gabuzda
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965

5.  Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis.

Authors:  S P Wilkinson; I K Smith; R Williams
Journal:  Hypertension       Date:  1979 Mar-Apr       Impact factor: 10.190

6.  Role of aldosterone in edema formation.

Authors:  H P Wolff; B H Blaise; G Düsterdieck; J Jahnecke; T Kobayashi; F Krück; D Lommer; H Schieffer
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

7.  9- -fluorohydrocortisone induced ascites in alcoholic liver disease.

Authors:  E K Denison; F L Lieberman; T B Reynolds
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

8.  Renal sodium retention in cirrhosis: relation to aldosterone and nephron site.

Authors:  S P Wilkinson; T P Jowett; J D Slater; V Arroyo; H Moodie; R Williams
Journal:  Clin Sci (Lond)       Date:  1979-02       Impact factor: 6.124

9.  Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure.

Authors:  F L Lieberman; T B Reynolds
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

10.  Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver.

Authors:  H Wernze; H J Spech; G Müller
Journal:  Klin Wochenschr       Date:  1978-04-15
View more
  12 in total

1.  Cardiac response to exercise in cirrhosis.

Authors:  R H Wachsberg
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 2.  Pathogenesis of ascites and hepatorenal syndrome.

Authors:  S P Wilkinson; K P Moore; V Arroyo
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Intravascular volume in cirrhosis. Reassessment using improved methodology.

Authors:  W G Rector; F Ibarra
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

Review 4.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

5.  Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.

Authors:  Giovanni Sansoè; Stefano Silvano; Giulio Mengozzi; Antonina Smedile; Giovanni Touscoz; Floriano Rosina; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

6.  Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.

Authors:  G Sansoè; F Wong
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

7.  Dopaminergic control of renal tubular function in patients with compensated cirrhosis.

Authors:  Giovanni Sansoè; Alberto Ferrari; Enrica Baraldi; Carmen Nives Castellana; Alessandra Biava; Stefano Silvano; Floriano Rosina; Lorenzo Bonardi; Federico Manenti
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

8.  Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.

Authors:  N Girgrah; P Liu; J Collier; L Blendis; F Wong
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

9.  Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.

Authors:  F Wong; P Liu; L Blendis
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

10.  Renal function impairment induced by change in posture in patients with cirrhosis and ascites.

Authors:  M Bernardi; C Santini; F Trevisani; M Baraldini; A Ligabue; G Gasbarrini
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.